Real-World Efficacy and Safety of Universal 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve Patients from a Nationwide HCV Registry in Taiwan.

Autor: Yang, Chun-Chi1 (AUTHOR), Huang, Chung-Feng2,3 (AUTHOR), Chang, Te-Sheng4,5 (AUTHOR), Lo, Ching-Chu6 (AUTHOR), Hung, Chao-Hung7 (AUTHOR), Huang, Chien-Wei8 (AUTHOR), Chong, Lee-Won9,10 (AUTHOR), Cheng, Pin-Nan11,12 (AUTHOR), Yeh, Ming-Lun2,13 (AUTHOR), Peng, Cheng-Yuan14,15 (AUTHOR), Cheng, Chien-Yu16 (AUTHOR), Huang, Jee-Fu2,13,17 (AUTHOR), Bair, Ming-Jong18,19 (AUTHOR), Lin, Chih-Lang20 (AUTHOR), Yang, Chi-Chieh21 (AUTHOR), Wang, Szu-Jen22 (AUTHOR), Hsieh, Tsai-Yuan23 (AUTHOR), Lee, Tzong-Hsi24 (AUTHOR), Lee, Pei-Lun25 (AUTHOR), Wu, Wen-Chih26 (AUTHOR)
Zdroj: Infectious Diseases & Therapy. Jun2024, Vol. 13 Issue 6, p1199-1213. 15p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje